Safe Orthopaedics SA (EPA:ALSAF)

Safe Orthopaedics Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	5.81	5.86	4.55	3.66	4.7
Revenue Growth (YoY)	-0.87%	28.70%	24.49%	-22.15%	35.38%
Cost of Revenue	1.59	2.2	1.98	2.26	3.42
Gross Profit	4.22	3.66	2.57	1.4	1.28
Selling, General & Admin	7.66	8.87	9.27	7.52	7.89
Other Operating Expenses	-0.13	-0.16	0.02	-0.03	0.45
Operating Expenses	10.41	9.62	10.16	8.07	8.73
Operating Income	-6.19	-5.96	-7.58	-6.67	-7.45
Interest Expense	-0.22	-0.42	-0.64	-0.86	-1.18
Interest & Investment Income	-	0.21	-	-	0.48
Currency Exchange Gain (Loss)	0.36	-0.64	1.51	-0.78	0.21
Other Non Operating Income (Expenses)	-263.48	-0.15	-0	0	-0.02
EBT Excluding Unusual Items	-269.52	-6.97	-6.71	-8.31	-7.97
Impairment of Goodwill	-1.79	-	-	-	-
Pretax Income	-271.32	-6.97	-6.71	-8.31	-7.97
Income Tax Expense	-65.87	-0	-	-	-
Net Income	-205.44	-6.97	-6.71	-8.31	-7.97
Net Income to Common	-205.44	-6.97	-6.71	-8.31	-7.97
Free Cash Flow	-1.19	-6.33	-8.22	-6.53	-4.29
Gross Margin	72.70%	62.52%	56.52%	38.25%	27.22%
Operating Margin	-106.45%	-101.69%	-166.47%	-182.26%	-158.52%
Profit Margin	-3536.04%	-118.84%	-147.32%	-227.06%	-169.61%
Free Cash Flow Margin	-20.52%	-107.95%	-180.41%	-178.59%	-91.27%
EBITDA	-5.34	-5	-6.72	-6.1	-7.06
EBITDA Margin	-91.94%	-85.33%	-147.45%	-166.73%	-150.18%
D&A For EBITDA	0.84	0.96	0.87	0.57	0.39
EBIT	-6.19	-5.96	-7.58	-6.67	-7.45
EBIT Margin	-106.45%	-101.69%	-166.47%	-182.26%	-158.52%
Advertising Expenses	0.04	0.11	0.07	0.04	0.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.